Search
Descriptor English: Wakefulness-Promoting Agents
Descriptor Spanish: Promotores de la Vigilia
Descriptor fármacos promotores de la vigilia
Entry term(s) agentes promotores de la vigilia
eugeroicos
fármaco promotor de la vigilia
medicamentos promotores de la vigilia
promotores de la vigilia
sustancias promotoras de la vigilia
Scope note: Categoría específica de fármacos que previenen la somnolencia actuando específicamente sobre los mecanismos cerebrales del sueño. Se utilizan en el tratamiento de los TRASTORNOS DE SOMNOLENCIA EXCESIVA COMO LA narcolepsia. Hay que señalar que esta categoría de fármacos no incluye los estimulantes del sistema nervioso central de amplio espectro de acción como las ANFETAMINAS.
Descriptor Portuguese: Promotores da Vigília
Descriptor French: Agents promoteurs de l'éveil
Entry term(s): Agents, Wake-Promoting
Agents, Wakefulness-Promoting
Drugs, Eugeroic
Drugs, Wake-Promoting
Eugeroic Drugs
Substances, Wake-Promoting
Wake Promoting Agents
Wake Promoting Drugs
Wake Promoting Substances
Wake-Promoting Agents
Wake-Promoting Drug
Wake-Promoting Drugs
Wake-Promoting Substances
Wakefulness Promoting Agents
Tree number(s): D27.505.954.427.220.612
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D064690
Scope note: A specific category of drugs that prevent sleepiness by specifically targeting sleep-mechanisms in the brain. They are used to treat DISORDERS OF EXCESSIVE SOMNOLENCE such as NARCOLEPSY. Note that this drug category does not include broadly-acting central nervous system stimulants such as AMPHETAMINES.
Allowable Qualifiers: AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Previous Indexing: Sleep Disorders/drug therapy (2006-2013)
Public MeSH Note: 2014
History Note: 2014
DeCS ID: 55346
Unique ID: D064690
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 2014/01/01
Date of Entry: 2013/07/08
Wakefulness-Promoting Agents - Preferred
Concept UI M0582998
Scope note A specific category of drugs that prevent sleepiness by specifically targeting sleep-mechanisms in the brain. They are used to treat DISORDERS OF EXCESSIVE SOMNOLENCE such as NARCOLEPSY. Note that this drug category does not include broadly-acting central nervous system stimulants such as AMPHETAMINES.
Preferred term Wakefulness-Promoting Agents
Entry term(s) Agents, Wake-Promoting
Agents, Wakefulness-Promoting
Drugs, Eugeroic
Drugs, Wake-Promoting
Eugeroic Drugs
Substances, Wake-Promoting
Wake Promoting Agents
Wake Promoting Drugs
Wake Promoting Substances
Wake-Promoting Agents
Wake-Promoting Drug
Wake-Promoting Drugs
Wake-Promoting Substances
Wakefulness Promoting Agents



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey